Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9920071rdf:typepubmed:Citationlld:pubmed
pubmed-article:9920071lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9920071lifeskim:mentionsumls-concept:C0222661lld:lifeskim
pubmed-article:9920071lifeskim:mentionsumls-concept:C0037657lld:lifeskim
pubmed-article:9920071lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:9920071lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:9920071lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:9920071pubmed:issue1lld:pubmed
pubmed-article:9920071pubmed:dateCreated1999-2-3lld:pubmed
pubmed-article:9920071pubmed:abstractTextTo investigate cortical bone composition and the role of the insulin-like growth factor (IGF) system in active acromegaly, iliac crest bone biopsies were obtained from 15 patients (3 women and 12 men), aged 21-64 yr (mean, 45.6 yr), and 25 age- and sex-matched controls (8 women and 17 men), aged 22-66 yr (mean, 44.6 yr). Levels of IGF-I, IGF-II, IGF-binding protein-3 (IGFBP-3), IGFBP-5, and total protein were determined in extracts obtained after ethylenediamine tetraacetate and guanidine hydrochloride extraction. Osteocalcin and calcium were determined in extracts after HCl hydrolysis. Cortical bone contents of IGF-I, IGF-II, and IGFBP-5 were significantly elevated in the acromegalic patients compared with control values [91% (P < 0.001), 44% (P < 0.04), and 115% (P < 0.004), respectively]. There was no significant difference in IGFBP-3, osteocalcin, protein, and calcium between patients and controls. This study suggests that the increased levels of growth factors in cortical bone from acromegalics is a reflection of local production, secondary to a chronic systemic excess of GH and IGF-I.lld:pubmed
pubmed-article:9920071pubmed:languageenglld:pubmed
pubmed-article:9920071pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9920071pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9920071pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9920071pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9920071pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9920071pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9920071pubmed:statusMEDLINElld:pubmed
pubmed-article:9920071pubmed:monthJanlld:pubmed
pubmed-article:9920071pubmed:issn0021-972Xlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:MosekildeLLlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:DjøselandOOlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:FlyvbjergAAlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:BrixenKKlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:BollerslevJJlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:HansenT BTBlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:EbbesenE NENlld:pubmed
pubmed-article:9920071pubmed:authorpubmed-author:UelandTTlld:pubmed
pubmed-article:9920071pubmed:issnTypePrintlld:pubmed
pubmed-article:9920071pubmed:volume84lld:pubmed
pubmed-article:9920071pubmed:ownerNLMlld:pubmed
pubmed-article:9920071pubmed:authorsCompleteYlld:pubmed
pubmed-article:9920071pubmed:pagination123-7lld:pubmed
pubmed-article:9920071pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:meshHeadingpubmed-meshheading:9920071-...lld:pubmed
pubmed-article:9920071pubmed:year1999lld:pubmed
pubmed-article:9920071pubmed:articleTitleIncreased cortical bone content of insulin-like growth factors in acromegalic patients.lld:pubmed
pubmed-article:9920071pubmed:affiliationDepartment of Endocrinology, National University Hospital, Oslo, Norway.lld:pubmed
pubmed-article:9920071pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9920071pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed